TriLink BioTechnologies, Inc. provides services for educators and academic researchers in gene therapy, nucleoside chemotherapy, oligonucleotide therapy, and diagnostics. It manufactures custom oligonucleotides, modified nucleoside triphosphates, and CleanAmp PCR products for research, diagnostic, therapeutic, and OEM markets; modified nucleic acid products, including phosphoramidites and other small molecules; and oligonucleotides, including custom synthesis and stocked oligonucleotides. The company also provides modified compounds, including aminoallyl, biotin, and two' fluoro nucleotides; specialty modified nucleotides, such as bisphosphates, a series of monophosphates, and CAP and mCAP; custom chemistry and contract research services, including the synthesis of unique phosphoramidites and polyphosphates, including mono-,di-and triphosphates, and other small molecules; and long RNA transcript synthesis and ISO/QSR compliant cGMP production facility services. In addition, it offers CleanAmp PCR kits, PCR reagents, dNTPs, GC-rich PCR, and primers and amidites. The company provides its products via online, email, and phone order. TriLink BioTechnologies, Inc. was founded in 1996 and is based in San Diego, California.|
